PDF Download

Total Page:16

File Type:pdf, Size:1020Kb

PDF Download Encephalopathies Caused by Electrolyte Disorders Martin A. Samuels, M.D.,1 and Julian Lawrence Seifter, M.D.2 ABSTRACT Some of the most common reasons for metabolic neurologic disturbances in the setting of a general hospital are frequently encountered electrolyte and related osmolality disorders. Hyperosmolality is usually related to hypernatremia and/or hyperglycemia. Identifying the cause and carefully calculating the water deficit is crucial to appropriate management. Hyponatremia may be hypertonic, isotonic, or hypotonic. When hypotonic, it may be hypervolemic, euvolemic, or hypovolemic in nature. Determining the precise nature of thehyponatremiaallowstheclinicianto focus the therapy appropriately. The rate of development of hyponatremia is crucial to safe and appropriate treatment. In acutely developing hyponatremia, hypertonic saline is required, whereas in slowly developing hyponatremia, water restriction and slow correction is required to avoid the syndrome of osmotic demyelination. Disorders of potassium metabolism are also common electrolyte disorders seen in the general hospital. Appropriate diagnosis and management of hyperkalemia and hypokalemia are also discussed. KEYWORDS: Hyperosmolarity, hypertonicity, hypernatremia, hyponatremia, hypokalemia, hyperkalemia HYPEROSMOLALITY AND Effective hyperosmolality is called hypertonicity HYPERTONICITY and indicates the effect of increased extracellular osmoles Normal serum, and therefore body fluid, osmolality is in to draw water from cells by osmosis. If hyperosmolality is the range of 275–295 mOsm/kg, but clinically signifi- due to hypernatremia, cells will initially shrink until cant deleterious effects are generally seen at levels greater adaptive mechanisms allow cell volume to recover. Sim- than 325 mOsm/kg. Osmolality may be measured di- ilarly, a diabetic with hyperglycemia will lose cell water rectly by freezing point depression or calculated as serum and develop a hypertonic syndrome. In contrast, osmolarity in mOsm/L, using the following formula, azotemia (i.e., an elevated blood urea nitrogen [BUN]) This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. which accounts for the millimolar quantities of major may cause hyperosmolality, but not hypertonicity be- serum solutes: cause the high cellular permeability of urea allows solute movement into cells so that cell water does not leave by 2Na ðmEq=LÞþglucoseðmg=dLÞ=18 osmosis. The difference between hyperglycemia (glucose þ BUNðmg=dLÞ=2:8 cannot enter cells) and azotemia is seen by the effect on 1Department of Neurology, 2Division of Nephrology, Brigham and Acute and Subacute Encephalopathies; Guest Editor, Martin A. Women’s Hospital, Harvard Medical School, Boston, Massachusetts. Samuels, M.D. Address for correspondence and reprint requests: Martin A. Semin Neurol 2011;31:135–138. Copyright # 2011 by Thieme Samuels, M.D., Chairman, Department of Neurology, Brigham and Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, Women’s Hospital, Professor of Neurology, Harvard Medical School, USA. Tel: +1(212) 584-4662. 75 Francis Street, Boston, MA 02115 (e-mail: msamuels@partners. DOI: http://dx.doi.org/10.1055/s-0031-1277983. org). ISSN 0271-8235. 135 136 SEMINARS IN NEUROLOGY/VOLUME 31, NUMBER 2 2011 the serum Na concentration. Water leaving cells in the 1. Calculate the normal total body water (NTBW) as: hyperglycemic patient lowers serum [Na], while [Na] is Body weight (in kg) Â 0.6 ¼ NTBW. not altered by a rise in BUN. Addition of extrinsic 2. Estimate the total body solute (TBS) (sodium þ osmoles such as mannitol, like glucose, causes hyper- potassium) as: NTBW Â 140 mEq/L ¼ TBS. Note osmolality, hypertonicity, loss of cell water, and hypo- that the 140 mEq/L is a normal serum [Na]. natremia. On the other hand, alcohols that quickly 3. Calculate the patient’s body water (PBW) as follows: permeate cells, like ethanol, ethylene glycol, isopropyl TBS/patients serum [Na] ¼ PBW. alcohol, and methanol act more like azotemia causing 4. Calculate the patient’s water deficit (PWD) as fol- hyperosmolality, but not hypertonicity or hyponatremia. lows: NTBW – PBW ¼ PWD. Because measured osmolality is increased with addition 5. Apart from deficit correction, estimate large ongoing of these extrinsic solutes, but Na, glucose, and urea are losses in the urine (osmotic diuresis or diabetes not, there is an osmolal gap defined as the difference insipidus) or sweat (fever) and replace. between measured and calculated osmolality. The osmo- lal gap should be < 10 mOsm/L. Replace the water losses so that the serum sodium Hypernatremia is defined as a serum sodium falls no faster than 2 mEq/L/h using water or 5% concentration of greater than 145 mEq/L. In other dextrose in water (D5W). In the hypotensive or vol- tissues, hypernatremia leads to loss of intracellular water ume-depleted patient, normal saline may first be needed leading to cell shrinkage. The nervous system is unique to correct blood pressure. In renal failure patients, in that it is capable of generating (or accumulating dialysis may be required. Insulin is administered, with from the extracellular fluid) solutes referred to as idio- frequent blood sugar testing, if there is hyperglycemia. genic osmoles, such as amino acids (glutamine, taurine, Intramuscular and subcutaneous insulin may be unpre- glutamate), polyols (myo-inositol), and methylamines dictably absorbed, particularly in hypovolemic patients (glycerophosphorylcholine, and choline) to minimize because of poor tissue perfusion. Rapid-acting insulin cell shrinkage, a process that is complete in 1 to 0.1 units/kg by rapid intravenous (IV) infusion followed 2 days. When hypernatremia is unusually severe (serum by 0.05 U/kg/h by continuous IV infusion is usually sodium over 160 mEq/L) these mechanisms fail, leading sufficient to reduce the blood sugar adequately and to encephalopathy. When hypernatremia occurs, anti- safely, but the mainstay of hyperglycemia correction in diuretic hormone (ADH) is released and thirst increases the hyperosmolar type II diabetic is volume expansion leading to renal retention of ingested water, thereby leading to urinary glucose clearance. Rapid reduction of lowering serum sodium toward normal. Hypernatremia extreme elevations of glucose should be avoided. is thus due to a defect in thirst or inability to access Diabetes insipidus (DI) is recognized as hyper- water, inadequate release or effect of ADH, loss of natremia (osm > 292) with simultaneous submaximal hypotonic fluid, or addition of concentrated sodium. concentration of the urine. A subcutaneous dose of Hyperglycemia is nearly always due to diabetes vasopressin and a serum ADH level will distinguish mellitus caused by inadequate insulin production (type I) central from nephrogenic DI. Treatments include dea- or insulin resistance (type II). In neurologic patients, this mino D-arginine vasopressin (DDAVP), an ADH ana- is often precipitated by stress, infection, or the thera- log used in central diabetes insipidus. Salt restriction and peutic use of glucocorticoids. Azotemia is due to renal even thiazide diuretics may help in nephrogenic diabetes failure or inadequate renal perfusion (prerenal azotemia). insipidus. Hyperosmolar agents, such as mannitol or glycerol, are often used in neurologic patients to treat increased intracranial pressure and may result in hyperosmolality. Hyponatremia Hyperosmolality usually produces a generalized Hyponatremia is defined as a serum sodium less than This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. encephalopathy without localizing or lateralizing fea- 135 mEq/L, but may be asymptomatic at levels less tures, but an underlying focal lesion (e.g., stroke, multi- than 125 mEq/L in chronic, slowly developing cases. ple sclerosis, neoplasm) could become symptomatic Hypotonicity is always associated with hyponatremia, under the metabolic stress of a hyperosmolar state. The but hyponatremia may be isotonic (e.g., as an artifact prognosis of the hyperosmolality itself is good, but the in hyperlipidemia, or hyperproteinemia); hypertonic long-term outlook depends upon the cause. For un- (e.g., hyperglycemia; mannitol); or hypotonic (impair- known reasons, hyperosmolality alone, particularly ment of free water excretion in low cardiac output when due to hyperglycemia, may lead to continuous states or the syndrome of inappropriate antidiuretic partial seizures, even when careful studies fail to uncover hormone (SIADH), or with an enormous free water any underlying lesion. These seizures generally respond load, as in psychogenic water drinking). Osmolality is promptly to lowering of the serum glucose. estimated using the formula above (see discussion of The treatment of hyperosmolality requires calcu- hyperosmolality) and may be measured in the clinical lation of apparent water losses. laboratory. The difference between the calculated and ENCEPHALOPATHIES CAUSED BY ELECTROLYTE DISORDERS/SAMUELS, SEIFTER 137 measured osmolality (the osmolal gap) should not (syndrome of inappropriate secretion of antidiuretic exceed 10 mOsm/L. Factitioushyponatremiaisdue hormone, psychogenic water drinking, hypothyroidism, to a laboratory artifact in diluted samples when the and resetting of the osmostat). The treatment depends solids of plasma are increased (e.g., hyperlipidemia, on the type of hyponatremia. In hypertonic hyponatre- severe hyperproteinemia as in myeloma). The undi- mia, one treats the underlying
Recommended publications
  • CURRENT Essentials of Nephrology & Hypertension
    a LANGE medical book CURRENT ESSENTIALS: NEPHROLOGY & HYPERTENSION Edited by Edgar V. Lerma, MD Clinical Associate Professor of Medicine Section of Nephrology Department of Internal Medicine University of Illinois at Chicago College of Medicine Associates in Nephrology, SC Chicago, Illinois Jeffrey S. Berns, MD Professor of Medicine and Pediatrics Associate Dean for Graduate Medical Education The Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania Allen R. Nissenson, MD Emeritus Professor of Medicine David Geffen School of Medicine at UCLA Los Angeles, California Chief Medical Offi cer DaVita Inc. El Segundo, California New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Lerma_FM_p00i-xvi.indd i 4/27/12 10:33 AM Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of the publisher. ISBN: 978-0-07-180858-3 MHID: 0-07-180858-2 The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-144903-8, MHID: 0-07-144903-5. All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked name, we use names in an editorial fashion only, and to the benefi t of the trademark owner, with no intention of infringement of the trademark.
    [Show full text]
  • 1 Fluid and Elect. Disorders of Serum Sodium Concentration
    DISORDERS OF SERUM SODIUM CONCENTRATION Bruce M. Tune, M.D. Stanford, California Regulation of Sodium and Water Excretion Sodium: glomerular filtration, aldosterone, atrial natriuretic factors, in response to the following stimuli. 1. Reabsorption: hypovolemia, decreased cardiac output, decreased renal blood flow. 2. Excretion: hypervolemia (Also caused by adrenal insufficiency, renal tubular disease, and diuretic drugs.) Water: antidiuretic honnone (serum osmolality, effective vascular volume), renal solute excretion. 1. Antidiuresis: hyperosmolality, hypovolemia, decreased cardiac output. 2. Diuresis: hypoosmolality, hypervolemia ~ natriuresis. Physiologic changes in renal salt and water excretion are more likely to favor conservation of normal vascular volume than nonnal osmolality, and may therefore lead to abnormalities of serum sodium concentration. Most commonly, 1. Hypovolemia -7 salt and water retention. 2. Hypervolemia -7 salt and water excretion. • HYFERNATREMIA Clinical Senini:: Sodium excess: salt-poisoning, hypertonic saline enemas Primary water deficit: chronic dehydration (as in diabetes insipidus) Mechanism: Dehydration ~ renal sodium retention, even during hypernatremia Rapid correction of hypernatremia can cause brain swelling - Management: Slow correction -- without rapid administration of free water (except in nephrogenic or untreated central diabetes insipidus) HYPONA1REMIAS Isosmolar A. Factitious: hyperlipidemia (lriglyceride-plus-plasma water volume). B. Other solutes: hyperglycemia, radiocontrast agents,. mannitol.
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • Cerebral Salt Wasting Syndrome and Systemic Lupus Erythematosus: Case Report
    Elmer ress Case Report J Med Cases. 2016;7(9):399-402 Cerebral Salt Wasting Syndrome and Systemic Lupus Erythematosus: Case Report Filipe Martinsa, c, Carolina Ouriquea, Jose Faria da Costaa, Joao Nuakb, Vitor Braza, Edite Pereiraa, Antonio Sarmentob, Jorge Almeidaa Abstract disorders, that results in hyponatremia and a decrease in ex- tracellular fluid volume. It is characterized by a hypotonic hy- Cerebral salt wasting (CSW) is a rare cause of hypoosmolar hypona- ponatremia with inappropriately elevated urine sodium con- tremia usually associated with acute intracranial disease character- centration in the setting of a normal kidney function [1-3]. ized by extracellular volume depletion due to inappropriate sodium The onset of this disorder is typically seen within the first wasting in the urine. We report a case of a 46-year-old male with 10 days following a neurological insult and usually lasts no recently diagnosed systemic lupus erythematosus (SLE) initially pre- more than 1 week [1, 2]. Pathophysiology is not completely senting with neurological involvement and an antiphospholipid syn- understood but the major mechanism might be the inappropri- drome (APS) who was admitted because of chronic asymptomatic ate and excessive release of natriuretic peptides which would hyponatremia previously assumed as secondary to syndrome of inap- result in natriuresis and volume depletion. A secondary neu- propriate antidiuretic hormone secretion (SIADH). Initial evaluation rohormonal response would result in an increase in the renin- revealed a hypoosmolar hyponatremia with high urine osmolality angiotensin system and consequently in antidiuretic hormone and elevated urinary sodium concentration. Clinically, the patient’s (ADH) production. Since the volume stimulus is more potent extracellular volume status was difficult to define accurately.
    [Show full text]
  • Electrolyte and Acid-Base
    Special Feature American Society of Nephrology Quiz and Questionnaire 2013: Electrolyte and Acid-Base Biff F. Palmer,* Mark A. Perazella,† and Michael J. Choi‡ Abstract The Nephrology Quiz and Questionnaire (NQ&Q) remains an extremely popular session for attendees of the annual meeting of the American Society of Nephrology. As in past years, the conference hall was overflowing with interested audience members. Topics covered by expert discussants included electrolyte and acid-base disorders, *Department of Internal Medicine, glomerular disease, ESRD/dialysis, and transplantation. Complex cases representing each of these categories University of Texas along with single-best-answer questions were prepared by a panel of experts. Prior to the meeting, program Southwestern Medical directors of United States nephrology training programs answered questions through an Internet-based ques- Center, Dallas, Texas; † tionnaire. A new addition to the NQ&Q was participation in the questionnaire by nephrology fellows. To review Department of Internal Medicine, the process, members of the audience test their knowledge and judgment on a series of case-oriented questions Yale University School prepared and discussed by experts. Their answers are compared in real time using audience response devices with of Medicine, New the answers of nephrology fellows and training program directors. The correct and incorrect answers are then Haven, Connecticut; ‡ briefly discussed after the audience responses, and the results of the questionnaire are displayed. This article and Division of recapitulates the session and reproduces its educational value for the readers of CJASN. Enjoy the clinical cases Nephrology, Department of and expert discussions. Medicine, Johns Clin J Am Soc Nephrol 9: 1132–1137, 2014.
    [Show full text]
  • Hyperkalemia Masked by Pseudo-Stemi Infarct Pattern and Cardiac Arrest Shareez Peerbhai1 , Luke Masha2, Adrian Dasilva-Deabreu1 and Abhijeet Dhoble1,2*
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Peerbhai et al. International Journal of Emergency Medicine (2017) 10:3 International Journal of DOI 10.1186/s12245-017-0132-0 Emergency Medicine CASEREPORT Open Access Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest Shareez Peerbhai1 , Luke Masha2, Adrian DaSilva-DeAbreu1 and Abhijeet Dhoble1,2* Abstract Background: Hyperkalemia is a common electrolyte abnormality and has well-recognized early electrocardiographic manifestations including PR prolongation and symmetric T wave peaking. With severe increase in serum potassium, dysrhythmias and atrioventricular and bundle branch blocks can be seen on electrocardiogram. Although cardiac arrest is a worrisome consequence of untreated hyperkalemia, rarely does hyperkalemia electrocardiographically manifest as acute ischemia. Case presentation: We present a case of acute renal failure complicated by malignant hyperkalemia and eventual ventricular fibrillation cardiac arrest. Recognition of this disorder was delayed secondary to an initial ECG pattern suggesting an acute ST segment elevation myocardial infarction (STEMI). Emergent coronary angiography performed showed no evidence of coronary artery disease. Conclusions: Pseudo-STEMI patterns are rarely seen in association with acute hyperkalemia and are most commonly described with patient without acute cardiac symptomatology. This is the first such case presenting concurrently with cardiac arrest. A brief review of this rare pseudo-infarct pattern is also given. Keywords: Cardiac arrest, Hyperkalemia, Myocardial infarction, STEMI, ECG Background Case presentation Hyperkalemia that manifests with electrocardiographic A 27-year-old Caucasian male with a past medical his- findings of an ST segment elevation myocardial infarc- tory of hypertension presented to the emergency room tion (STEMI) is very rare.
    [Show full text]
  • Parenteral Nutrition Primer: Balance Acid-Base, Fluid and Electrolytes
    Parenteral Nutrition Primer: Balancing Acid-Base, Fluids and Electrolytes Phil Ayers, PharmD, BCNSP, FASHP Todd W. Canada, PharmD, BCNSP, FASHP, FTSHP Michael Kraft, PharmD, BCNSP Gordon S. Sacks, Pharm.D., BCNSP, FCCP Disclosure . The program chair and presenters for this continuing education activity have reported no relevant financial relationships, except: . Phil Ayers - ASPEN: Board Member/Advisory Panel; B Braun: Consultant; Baxter: Consultant; Fresenius Kabi: Consultant; Janssen: Consultant; Mallinckrodt: Consultant . Todd Canada - Fresenius Kabi: Board Member/Advisory Panel, Consultant, Speaker's Bureau • Michael Kraft - Rockwell Medical: Consultant; Fresenius Kabi: Advisory Board; B. Braun: Advisory Board; Takeda Pharmaceuticals: Speaker’s Bureau (spouse) . Gordon Sacks - Grant Support: Fresenius Kabi Sodium Disorders and Fluid Balance Gordon S. Sacks, Pharm.D., BCNSP Professor and Department Head Department of Pharmacy Practice Harrison School of Pharmacy Auburn University Learning Objectives Upon completion of this session, the learner will be able to: 1. Differentiate between hypovolemic, euvolemic, and hypervolemic hyponatremia 2. Recommend appropriate changes in nutrition support formulations when hyponatremia occurs 3. Identify drug-induced causes of hypo- and hypernatremia No sodium for you! Presentation Outline . Overview of sodium and water . Dehydration vs. Volume Depletion . Water requirements & Equations . Hyponatremia • Hypotonic o Hypovolemic o Euvolemic o Hypervolemic . Hypernatremia • Hypovolemic • Euvolemic • Hypervolemic Sodium and Fluid Balance . Helpful hint: total body sodium determines volume status, not sodium status . Examples of this concept • Hypervolemic – too much volume • Hypovolemic – too little volume • Euvolemic – normal volume Water Distribution . Total body water content varies from 50-70% of body weight • Dependent on lean body mass: fat ratio o Fat water content is ~10% compared to ~75% for muscle mass .
    [Show full text]
  • ACP NATIONAL ABSTRACTS COMPETITIONS MEDICAL STUDENTS 2019 Table of Contents
    ACP NATIONAL ABSTRACTS COMPETITIONS MEDICAL STUDENTS 2019 Table of Contents MEDICAL STUDENT RESEARCH PODIUM PRESENTATIONS ...................................................................... 8 COLOMBIA RESEARCH PODIUM PRESENTATION - Andrey Sanko ........................................................ 9 Clinical Factors Associated with High Glycemic Variability Defined by the Variation Coefficient in Patients with Type 2 Diabetes .......................................................................................................... 9 MARYLAND RESEARCH PODIUM PRESENTATION - Asmi Panigrahi ................................................... 11 Influence of Individual-Level Neighborhood Factors on Health Promoting and Risk Behaviors in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) ........................................... 11 NEW YORK RESEARCH PODIUM PRESENTATION - Kathryn M Linder ................................................ 13 Implementation of a Medical Student-Led Emergency Absentee Ballot Voting Initiative at an Urban Tertiary Care University Hospital ......................................................................................... 13 OREGON RESEARCH PODIUM PRESENTATION - Sherry Liang ............................................................ 15 A Novel Student-Led Improvement Science Curriculum for Pre-Clinical Medical Students .......... 15 TENNESSEE RESEARCH PODIUM PRESENTATION - Zara Latif ............................................................. 17 Impaired Brain Cells Response in Obesity
    [Show full text]
  • Severe Hyponatremia in a COVID-19 Patient
    http://crim.sciedupress.com Case Reports in Internal Medicine 2020, Vol. 7, No. 3 CASE REPORTS Severe hyponatremia in a COVID-19 patient Waqar Haider Gaba∗1, Sara Al Hebsi2, Rania Abu Rahma3 1Consultant Physician Internal Medicine, Sheikh Khalifa Medical, Abu Dhabi, United Arab Emirates 2Medical Resident Internal Medicine, Sheikh Khalifa Medical, Abu Dhabi, United Arab Emirates 3Nephrology Specialist, Sheikh Khalifa Medical, Abu Dhabi, United Arab Emirates Received: August 13, 2020 Accepted: August 31, 2020 Online Published: September 23, 2020 DOI: 10.5430/crim.v7n3p15 URL: https://doi.org/10.5430/crim.v7n3p15 ABSTRACT Hyponatremia is one of the most common electrolyte abnormalities found in hospitalized patients. The diagnosis of the underlying cause of hyponatremia could be challenging. However, common causes include the syndrome of inappropriate anti-diuretic hormone (SIADH), diuretic use, polydipsia, adrenal insufficiency, hypovolemia, heart failure, and liver cirrhosis. The ongoing pandemic of coronavirus disease 2019 (COVID-19) can present with severe hyponatremia. The association of hyponatremia and COVID-19 infection has been described, though pathophysiology is not clear. Here we describe a case of a 61-year-old male who presented with severe hyponatremia (Na+ 100 mmol/L) thought to be secondary to SIADH associated with COVID-19 pneumonia. Key Words: Hyponatremia, COVID-19, Syndrome of Inappropriate Antidiuretic Hormone (SIADH) 1.I NTRODUCTION sense RNA virus. It causes mild respiratory symptoms simi- lar to a common cold. Around 50% of COVID-19 positive Hyponatremia is defined as a serum sodium concentration patients were found to have hyponatremia on admission.[2] < 135 mEq/L. Clinical presentation could vary from mild to severe or life-threatening.
    [Show full text]
  • Electrolyte Disorders and Arrhythmogenesis
    Cardiology Journal 2011, Vol. 18, No. 3, pp. 233–245 Copyright © 2011 Via Medica REVIEW ARTICLE ISSN 1897–5593 Electrolyte disorders and arrhythmogenesis Nabil El-Sherif1, Gioia Turitto2 1State University of NY, Downstate Medical Center and NY Harbor VA Healthcare System, Brooklyn, NY, USA 2Methodist University Hospital, Brooklyn, NY, USA Abstract Electrolyte disorders can alter cardiac ionic currents kinetics and depending on the changes can promote proarrhythmic or antiarrhythmic effects. The present report reviews the mecha- nisms, electrophysiolgical (EP), electrocardiographic (ECG), and clinical consequences of elec- trolyte disorders. Potassium (K+) is the most abundent intracellular cation and hypokalemia is the most commont electrolyte abnormality encountered in clinical practice. The most signifcant ECG manifestation of hypokalemia is a prominent U wave. Several cardiac and + non cardiac drugs are known to suppress the HERG K channel and hence the IK, and especially in the presence of hypokalemia, can result in prolonged action potential duration and QT interval, QTU alternans, early afterdepolarizations, and torsade de pointes ventricu- lar tachyarrythmia (TdP VT). Hyperkalemia affects up to 8% of hospitalized patients mainly in the setting of compromised renal function. The ECG manifestation of hyperkalemia de- pends on serum K+ level. At 5.5–7.0 mmol/L K+, tall peaked, narrow-based T waves are seen. At > 10.0 mmol/L K+, sinus arrest, marked intraventricular conduction delay, ventricular techycardia, and ventricular fibrillation can develop. Isolated abnormalities of extracellular calcium (Ca++) produce clinically significant EP effects only when they are extreme in either direction. Hypocalcemia, frequently seen in the setting of chronic renal insufficiency, results in prolonged ST segment and QT interval while hypercalcemia, usually seen with hyperparathy- roidism, results in shortening of both intervals.
    [Show full text]
  • Hypercalcemia and Hyponatremia
    Hypercalcemia and Hyponatremia Santosh Reddy MD FACP Assistant Professor Scott & White/Texas A&M Etiology of Hypercalcemia Hypercalcemia results when the entry of calcium into the circulation exceeds the excretion of calcium into the urine or deposition in bone. Sources of calcium are most commonly the bone or the gastrointestinal tract Etiology Hypercalcemia is a relatively common clinical problem. Elevation in the physiologically important ionized (or free) calcium concentration. However, 40 to 45 percent of the calcium in serum is bound to protein, principally albumin; , increased protein binding causes elevation in the serum total calcium. Increased bone resorption Primary and secondary hyperparathyroidism Malignancy Hyperthyroidism Other - Paget's disease, estrogens or antiestrogens in metastatic breast cancer, hypervitaminosis A, retinoic acid Increased intestinal calcium absorption Increased calcium intake Renal failure (often with vitamin D supplementation) Milk-alkali syndrome Hypervitaminosis D Enhanced intake of vitamin D or metabolites Chronic granulomatous diseases (eg, sarcoidosis) Malignant lymphoma Acromegaly Pseudocalcemia Hyperalbuminemia 1) severe dehydration 2) multiple myeloma who have a calcium- binding paraprotein. This phenomenon is called pseudohypercalcemia (or factitious hypercalcemia) Other causes Familial hypocalciuric hypercalcemia Chronic lithium intake Thiazide diuretics Pheochromocytoma Adrenal insufficiency Rhabdomyolysis and acute renal failure Theophylline toxicity Immobilization
    [Show full text]
  • Medical Term Lay Term(S)
    MEDICAL TERM LAY TERM(S) ABDOMINAL Pertaining to body cavity below diaphragm which contains stomach, intestines, liver, and other organs ABSORB Take up fluids, take in ACIDOSIS Condition when blood contains more acid than normal ACUITY Clearness, keenness, esp. of vision - airways ACUTE New, recent, sudden ADENOPATHY Swollen lymph nodes (glands) ADJUVANT Helpful, assisting, aiding ADJUVANT Added treatment TREATMENT ANTIBIOTIC Drug that kills bacteria and other germs ANTIMICROBIAL Drug that kills bacteria and other germs ANTIRETROVIRAL Drug that inhibits certain viruses ADVERSE EFFECT Negative side effect ALLERGIC REACTION Rash, trouble breathing AMBULATE Walk, able to walk -ATION -ORY ANAPHYLAXIS Serious, potentially life threatening allergic reaction ANEMIA Decreased red blood cells; low red blood cell count ANESTHETIC A drug or agent used to decrease the feeling of pain or eliminate the feeling of pain by general putting you to sleep ANESTHETIC A drug or agent used to decrease the feeling of pain or by numbing an area of your body, local without putting you to sleep ANGINA Pain resulting from insufficient blood to the heart (ANGINA PECTORIS) ANOREXIA Condition in which person will not eat; lack of appetite ANTECUBITAL Area inside the elbow ANTIBODY Protein made in the body in response to foreign substance; attacks foreign substance and protects against infection ANTICONVULSANT Drug used to prevent seizures ANTILIPIDEMIC A drug that decreases the level of fat(s) in the blood ANTITUSSIVE A drug used to relieve coughing ARRHYTHMIA Any change from the normal heartbeat (abnormal heartbeat) ASPIRATION Fluid entering lungs ASSAY Lab test ASSESS To learn about ASTHMA A lung disease associated with tightening of the air passages ASYMPTOMATIC Without symptoms AXILLA Armpit BENIGN Not malignant, usually without serious consequences, but with some exceptions e.g.
    [Show full text]